Expression and clinical value of the plasma peroxiredoxin family in early pregnancy for predicting subsequent gestational diabetes mellitus

Table 6 Univariate logistic regression analysis in women with early gestational diabetes mellitus

Indicators	B	SE	Wald χ2	P value	OR	95%CI
Age	0.214	0.025	76.460	0.000	1.239	1.181-1.300
Height	-0.370	1.475	0.063	0.802	0.691	0.038-12.435
Pre-pregnancy weight	0.125	0.013	98.767	0.000	1.133	1.105-1.161
Pre-pregnancy BMI	0.290	0.030	94.076	0.000	1.336	1.260-1.417
Mid-pregnancy weight	0.147	0.014	109.143	0.000	1.159	1.127-1.191
Mid-pregnancy BMI	0.323	0.031	106.737	0.000	1.381	1.299-1.468
Birth history	-0.126	0.190	0.441	0.506	0.881	0.607-1.279
Triglyceride	0.486	0.066	54.474	0.000	1.627	1.429-1.851
Total cholesterol	0.060	0.057	1.108	0.292	1.062	0.949-1.188
HDL-C	-0.59	0.286	4.263	0.039	0.554	0.316-0.970
LDL-C	2.186	0.230	90.347	0.000	8.900	5.670-13.968
Fasting blood glucose	1.304	0.167	60.640	0.000	3.682	2.652-5.112
Glycated hemoglobin	3.076	0.274	126.471	0.000	21.678	12.682-37.057
PRDX1	0.016	0.002	68.788	0.000	1.016	1.012-1.019
PRDX2	0.008	0.002	13.451	0.000	1.008	1.004-1.012
PRDX3	0.007	0.001	24.873	0.000	1.007	1.004-1.009
PRDX4	0.017	0.002	69.990	0.000	1.017	1.013-1.021
PRDX5	0.018	0.002	57.480	0.000	1.018	1.013-1.023
PRDX6	0.002	0.000	14.550	0.000	1.002	1.001-1.003

BMI: Body mass index; HDL-C: High-density lipoprotein-cholesterol; LDL-C: Low-density lipoprotein-cholesterol; PRDX: Peroxiredoxin; CI: Confidence interval; OR: Odds ratio.